HOME ›  業績一覧 ›  2016年業績

業績一覧

2016年業績

欧文原著 - 当研究室の2016年の業績です。

 

    1. Chubachi S, Yasuda H, Irie H, Fukunaga K, Naoki K, Soejima K, Betsuyaku T. A Case of Non-Small Cell Lung Cancer with Possible "Disease Flare" on Nivolumab Treatment. Case Rep Oncol Med. 2016;2016:1075641. doi: 10.1155/2016/1075641. PMID: 28116195　
    2. Nakajima T, Nakamura H, Owen CA, Yoshida S, Tsuduki K, Chubachi S, Shirahata T, Mashimo S, Nakamura M, Takahashi S, Minematsu N, Tateno H, Fujishima S, Asano K, Celli BR, Betsuyaku T. Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD. Dis Markers. 2016;2016:4093870. PMID: 27994288
    3. Ikemura S, Aramaki N, Fujii S, Kirita K, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Kuwata T, Kojima M, Ochiai A, Betsuyaku T, Tsuboi M, Goto K, Ishii G. Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma. Cancer Sci. 2016 Oct 20. doi: 10.1111/cas.13110. PMID: 27761967
    4. Miyawaki M, Yasuda H, Tani T, Hamamoto J, Arai D, Ishioka K, Ohgino K, Nukaga S, Hirano T, Kawada I, Naoki K, Hayashi Y, Betsuyaku T, Soejima K. Overcoming EGFR bypass signal-induced acquired resistance to ALK tyrosine kinase inhibitors in ALK-translocated lung cancer. Mol Cancer Res. 2016 Oct 5. pii: molcanres.0211.2016. PMID: 27707887
    5. Funatsu Y, Tasaka S, Asami T, Namkoong H, Fujiwara H, Iketani O, Yagi K, Kimizuka Y, Ishii M, Nishimura T, Ogata H, Iwata S, Betsuyaku T, Hasegawa N. Pharmacokinetics of intravenous peramivir in the airway epithelial lining fluid of healthy volunteers. Antivir Ther. 2016 Oct 3. doi: 10.3851/IMP3096. PMID: 27694694
    6. Tani T, Naoki K, Asakura T, Hirano T, Suzuki S, Masuzawa K, Hasegawa H, Kuroda A, Yasuda H, Ishii M, Soejima K, Betsuyaku T. Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report. Mol Clin Oncol. 2016 Oct;5(4):488-490. PMID: 27699048
    7. Morimoto K, Namkoong H, Hasegawa N, Nakagawa T, Morino E, Shiraishi Y, Ogawa K, Izumi K, Takasaki J, Yoshiyama T, Hoshino Y, Matsuda S, Hayashi Y, Sasaki Y, Ishii M, Kurashima A, Nishimura T, Betsuyaku T, Goto H; Nontuberculous Mycobacteriosis Japan Research Consortium (NTM-JRC). Macrolide-Resistant Mycobacterium avium Complex Lung Infection: An Analysis of 102 Consecutive Cases. Ann Am Thorac Soc. 2016 Aug 11. PMID: 27513168
    8. Namkoong H, Morimoto K, Nishimura T, Tanaka H, Sugiura H, Yamada Y, Kurosaki A, Asakura T, Suzuki S, Fujiwara H, Yagi K, Ishii M, Tasaka S, Betsuyaku T, Hoshino Y, Kurashima A, Hasegawa N. Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series. BMC Infect Dis. 2016 Aug 9;16:396. doi: 10.1186/s12879-016-1689-6. PMID: 27506679
    9. Chubachi S, Sato M, Kameyama N, Tsutsumi A, Sasaki M, Tateno H, Nakamura H, Asano K, Betsuyaku T; Keio COPD Comorbidity Research (K-CCR) Group. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort. Respir Med. 2016 Aug;117:272-9. doi: 10.1016/j.rmed.2016.07.002. PMID: 27492541
    10. Yagi K, Ishii M, Namkoong H, Fujii H, Asami T, Suzuki S, Asakura T, Mizoguchi K, Kamo T, Tasaka S, Iwata S, Kunkel SL, Hasegawa N, Betsuyaku T. Histone Deacetylase Inhibition Protects Mice Against Lethal Postinfluenza Pneumococcal Infection. Crit Care Med. 2016 Oct;44(10):e980-7. doi: 10.1097/CCM.0000000000001821. PMID: 27352127
    11. Suzuki S, Morino E, Ishii M, Namkoong H, Yagi K, Asakura T, Asami T, Fujiwara H, Uwamino Y, Nishimura T, Tasaka S, Betsuyaku T, Takasaki J, Iwata S, Hasegawa N. Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in 2001-2011: A case series and literature review. J Infect Chemother. 2016 Jul 9. pii: S1341-321X(16)30093-9. doi: 10.1016/j.jiac.2016.06.006. [Epub ahead of print] PMID: 27406572
    12. Sato M, Chubachi S, Sasaki M, Haraguchi M, Kameyama N, Tsutsumi A, Takahashi S, Nakamura H, Asano K, Betsuyaku T. Impact of mild exacerbation on COPD symptoms in a Japanese cohort. Int J Chron Obstruct Pulmon Dis. 2016 Jun 9;11:1269-78. doi: 10.2147/COPD.S105454. eCollection 2016. PMID: 27354785
    13. Hegab AE, Kameyama N, Kuroda A, Kagawa S, Yin Y, Ornitz D, Betsuyaku T. Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer. J Vis Exp. 2016 May 20;(111). doi: 10.3791/53904. PMID: 27286135
    14. Nukaga S, Naoki K, Kamo T, Masuzawa K, Yasuda H, Soejima K, Betsuyaku T. Alectinib as a treatment option following recovery from crizotinib-induced interstitial lung disease in patients with anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. Mol Clin Oncol. 2016 Jun;4(6):1085-1087. Epub 2016 Mar 30. PMID: 27284449
    15. Asakura T, Kameyama N, Ishii M, Kawada I, Tasaka S, Soejima K, Betsuyaku T. Multiple nodular lesions following Pneumocystis pneumonia in a non-HIV immunocompromised patient. Clin Case Rep. 2016 Apr 1;4(5):528-30. doi: 10.1002/ccr3.555. eCollection 2016 May. PMID: 27190623
    16. Kamo T, Tasaka S, Tokuda Y, Suzuki S, Asakura T, Yagi K, Namkoong H, Ishii M, Hasegawa N, Betsuyaku T.Levels of Soluble Receptor for Advanced Glycation End Products in Bronchoalveolar Lavage Fluid in Patients with Various Inflammatory Lung Diseases.Clin Med Insights Circ Respir Pulm Med. 2016 Apr 28;9(Suppl 1):147-54. doi: 10.4137/CCRPM.S23326. eCollection 2015.PMID: 27147899
    17. Terashima T, Chubachi S, Matsuzaki T, Nakajima T, Satoh M, Iwami E, Yoshida K, Katakura A, Betsuyaku T.The association between dental health and nutritional status in chronic obstructive pulmonary disease.Chron Respir Dis. 2016 Apr 6. pii: 1479972316643076.
    18. Kabata H, Moro K, Koyasu S, Fukunaga K, Asano K, Betsuyaku T.Mechanisms to Suppress ILC2-induced Airway Inflammation.Ann Am Thorac Soc. 2016 Mar;13 Suppl 1:S95. doi: 10.1513/AnnalsATS.201508-557MG.
    19. Asakura T, Ishii M, Kikuchi T, Kameyama K, Namkoong H, Nakata N, Sugita K, Tasaka S, Shimizu T, Hoshino Y, Okamoto S, Betsuyaku T, Hasegawa N. Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report. Medicine (Baltimore). 2016 Mar;95(11):e3131. doi: 10.1097/MD.0000000000003131.
    20. Haraguchi M, Nakamura H, Sasaki M, Miyazaki M, Chubachi S, Takahashi S, Asano K, Jones PW, Betsuyaku T; Keio COPD Comorbidity Research (K-CCR) Group. Determinants of chronic obstructive pulmonary disease severity in the late-elderly differ from those in younger patients. BMC Res Notes. 2016 Jan 4;9(1):7. doi: 10.1186/s13104-015-1810-8.

トピックス

  • 同門会（要パスワード）
  • サタデーレクチャー（要パスワード）
  • 寄附講座
  • 患者様へ 臨床研究について

page top

Copyright(c) 2024 Keio University Hospital. All rights reserved.